≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Other and unspecified disorders of psychological development

EFO MESH Endpoint Browser PheWeb

F5_PSYCHDEVOTH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F88, F89
  • Hospital discharge: ICD-9 — 3159
  • Cause of death: ICD-10 — F88, F89
  • Cause of death: ICD-9 — 3159

2 out of 7 registries used, show all original rules.

453

4. Check minimum number of events

None

453

5. Include endpoints

None

453

6. Filter based on genotype QC (FinnGen only)

419

Control definitions (FinnGen only)

Control exclude
F5_PSYCHDEV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11758 3380 8372
Only index persons 8924 2658 6266
Unadjusted period prevalence (%)
Whole population 0.19 0.10 0.23
Only index persons 0.20 0.10 0.24
Median age at first event (years)
Whole population 8.17 8.75 7.94
Only index persons 9.13 9.99 8.76

-FinnGen-

Key figures

All Female Male
Number of individuals 419 169 250
Unadjusted period prevalence (%) 0.09 0.06 0.11
Median age at first event (years) 9.49 11.63 8.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
453
Matched controls
4440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F88
ICD-10 Finland
Other disorders of psychological development
670.4
210.8
194
5
F89
ICD-10 Finland
Unspecified disorder of psychological development
762.7
203.7
187
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
117.1
108
*
IGV01
NOMESCO Finland
Psychiatric network contact
19.5
105.9
89
55
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
13.4
103.0
110
104
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.6
98.4
127
157
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
9.8
93.6
129
173
IGP01
NOMESCO Finland
Psychiatric family contact
12.1
83.3
93
93
IGY99
NOMESCO Finland
Other psychiatric treatment contact
10.2
81.5
105
128
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
27.6
80.5
57
23
N05AX08
ATC
risperidone; systemic
9.4
77.1
106
140
IEV99
NOMESCO Finland
Other psychiatric network intervention
18.5
69.1
58
35
F83
ICD-10 Finland
Mixed specific developmental disorders
752.5
68.4
66
*
ZY010
NOMESCO Finland
Hospital outpatient
7.0
65.8
121
220
Z2445
NOMESCO Finland
Psychologist
7.1
65.1
116
204
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
9.1
64.5
88
114
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.9
60.0
136
301
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
11.1
59.9
69
71
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
9.8
57.9
73
85
IEP99
NOMESCO Finland
Other psychiatric family intervention
13.8
57.0
56
45
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
15.8
53.2
48
33
N05AX12
ATC
aripiprazole; systemic
7.6
52.0
83
128
ZYC01
NOMESCO Finland
Remote contact by phone
6.8
48.4
85
145
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.5
48.1
160
479
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
12.1
47.2
50
45
R62.0
ICD-10 Finland
Delayed milestone
11.9
46.6
50
46
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
7.4
45.8
73
112
XA800
NOMESCO Finland
Neuropsychological investigation
7.6
45.6
71
106
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.8
45.4
97
200
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
166.8
44.3
46
*
F84.5
ICD-10 Finland
Asperger syndrome
76.6
43.6
49
7
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
12.4
43.5
45
39
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.5
43.1
79
140
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
43.1
41
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.5
42.6
78
138
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.0
42.5
86
168
IEP03
NOMESCO Finland
Focused parental counselling
9.4
42.4
54
63
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
6.0
39.8
79
151
F82
ICD-10 Finland
Specific developmental disorder of motor function
113.2
39.1
42
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.4
38.7
120
335
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.1
38.4
94
217
N05AH03
ATC
olanzapine; systemic
5.6
37.8
81
166
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
6.5
37.6
67
115
N06BA04
ATC
methylphenidate; oral
4.6
37.4
105
271
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
10.1
36.8
44
47
F93.89
ICD-10 Finland
Other childhood emotional disorders
9.0
36.6
48
58
N03AG01
ATC
valproic acid; systemic, rectal
6.1
36.5
70
129
Z2446
NOMESCO Finland
Social worker
4.2
36.5
120
349
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
9.4
36.4
46
53
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.3
34.3
78
168
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.9
32.7
64
120
F80.1
ICD-10 Finland
Expressive language disorder
174.0
31.9
33
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.8
31.1
80
191
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
168.3
30.8
32
*
IER01
NOMESCO Finland
Psychoeducation, group
12.5
30.4
31
26
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.6
30.0
62
122
Z2221
NOMESCO Finland
Medical doctor
3.2
29.5
176
743
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
7.6
29.4
44
62
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
+∞
29.3
28
*
Z3226
NOMESCO Finland
Physiotherapist
3.3
28.8
145
552
R5599
NOMESCO Finland
Other rehabilitation service
8.2
28.6
40
52
N05AH04
ATC
quetiapine; oral
3.3
27.4
132
488
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
62.8
26.1
30
5
Z3231
NOMESCO Finland
Registered nurse
2.9
25.8
204
991
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.2
25.8
57
119
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.9
24.9
48
88
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.9
24.8
59
131
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.9
24.7
83
241
N03AX09
ATC
lamotrigine; oral
5.2
24.5
55
116
IEP02
NOMESCO Finland
Child-centred family therapy
6.0
24.1
45
80
F84.0
ICD-10 Finland
Childhood autism
+∞
24.0
23
*
F80.2
ICD-10 Finland
Receptive language disorder
123.9
22.6
24
*
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
118.5
21.6
23
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
21.5
105
386
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
61.9
20.9
24
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
20.8
20
*
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
6.5
19.9
34
55
R4120
NOMESCO Finland
Occupational therapy
4.6
19.8
50
116
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.5
19.7
40
77
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
71.6
18.7
21
*
T82
ICPC
Obesity
6.3
18.3
32
53
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.3
18.0
27
38
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
13.6
17.5
30
23
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
6.0
17.4
32
56
P99
ICPC
Psychological disorders other
5.5
17.1
34
64
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
15.5
16.7
27
18
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
40.9
16.3
20
5
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.8
16.3
31
56
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
15.8
16.2
26
17
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.7
15.9
55
161
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
13.3
15.7
27
21
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
14.3
15.0
25
18
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.4
14.8
25
40
N05AA02
ATC
levomepromazine; systemic
6.1
14.6
26
44
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
14.5
14
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.3
14.4
25
41
N05AH02
ATC
clozapine; systemic
6.1
14.1
25
42
N05BA06
ATC
lorazepam; systemic, sublingual
6.3
14.0
24
39
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
13.0
13.9
24
19
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.6
13.8
49
146
ZXY60
NOMESCO Finland
2-person team, nurses
16.5
13.4
21
13
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
40.6
13.1
16
*
N06AB06
ATC
sertraline; oral
2.8
12.8
73
288
P22
ICPC
Child behaviour symptom/complaint
3.5
12.7
47
144
N06AB04
ATC
citalopram; systemic
3.0
12.6
62
225
ZY000
NOMESCO Finland
Hospital inpatient
5.9
12.5
23
40
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
20.3
12.4
18
9
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.8
12.4
29
63
RT150, ,
NOMESCO Finland
11.9
12.3
22
19
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.7
12.2
70
277
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
12.0
60
220
ICB06, ,
NOMESCO Finland
10.3
12.0
23
23
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
11.9
101
481
N05AB03
ATC
perphenazine; systemic, rectal
5.6
11.9
23
42
N06AB03
ATC
fluoxetine; oral
3.0
11.9
57
204
A28
ICPC
Limited function/disability NOS
3.3
11.9
46
145
N05BA01
ATC
diazepam; systemic, rectal
3.2
11.8
49
161
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
11.8
51
172
SPAT1389
SPAT
Visit based on need for special support
2.7
11.6
68
271
RL140, ,
NOMESCO Finland
13.8
11.4
19
14
RT420, ,
NOMESCO Finland
35.3
11.2
14
*
F81.0
ICD-10 Finland
Specific reading disorder
20.3
11.1
16
8
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
10.2
11.0
21
21
P24
ICPC
Specific learning problem
4.0
10.9
32
83
IEP01
NOMESCO Finland
Psychoeducation, family
9.0
10.7
22
25
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.2
10.7
29
71
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.6
10.7
65
264
F90.8
ICD-10 Finland
Other hyperkinetic disorders
21.7
10.6
15
7
Z50.5
ICD-10 Finland
Speech therapy
3.7
10.6
35
99
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.0
10.5
23
47
RL130, ,
NOMESCO Finland
11.4
10.5
19
17
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
10.0
62
254
G47.3
ICD-10 Finland
Sleep apnoea
2.7
10.0
59
236
P29
ICPC
Psychological sympt/compl other
2.5
9.9
70
305
XA820, ,
NOMESCO Finland
14.7
9.9
16
11
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
40.2
9.9
12
*
R4130
NOMESCO Finland
Speech therapy
5.1
9.9
21
42
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.0
9.9
46
162
RS140, ,
NOMESCO Finland
13.5
9.6
16
12
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
9.5
39
127
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
9.3
9
*
ZXY02
NOMESCO Finland
Neuropsychologist
12.5
9.3
16
13
183
Kela drug reimbursment
Lamotrigin and topiramate
8.8
9.2
19
22
OAB43, ,
SPAT
0.4
9.2
58
1158
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.0
9.2
26
66
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
9.1
43
152
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
13.8
9.1
15
11
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.7
9.1
21
45
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
7.5
8.9
20
27
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
18.7
8.9
13
7
N03AF02
ATC
oxcarbazepine; oral
3.7
8.8
28
77
N05BA09
ATC
clobazam; oral
6.9
8.8
21
31
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
8.7
40
140
IAB03
NOMESCO Finland
Neuropsychiatric consultation
50.0
8.6
10
*
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
50.0
8.6
10
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.4
8.6
32
98
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
8.5
92
479
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
11.6
8.5
15
13
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.7
8.5
46
176
RT120, ,
NOMESCO Finland
27.6
8.4
11
*
ZYB05
NOMESCO Finland
Outreach service at patient’s workplace, school or occupational/school health care
20.1
8.4
12
6
F81.1
ICD-10 Finland
Specific spelling disorder
89.9
8.4
9
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
8.3
41
149
N06AX16
ATC
venlafaxine; oral
2.4
8.2
60
265
F91.3
ICD-10 Finland
Oppositional defiant disorder
14.5
8.1
13
9
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
11.8
8.0
14
12
N04AA02
ATC
biperiden; systemic
11.8
8.0
14
12
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
22.0
8.0
11
5
N03AF01
ATC
carbamazepine; oral, rectal
7.3
7.9
18
25
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
7.8
82
422
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
10.8
7.7
14
13
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
10.8
7.7
14
13
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.5
7.7
19
43
3459X
ICD-9 Finland
Epilepsy, unspecified
44.9
7.7
9
*
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
44.9
7.7
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
7.6
81
418
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
3.7
7.6
24
66
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
18.4
7.5
11
6
R1260
NOMESCO Finland
Evaluation of communicative skills
8.1
7.5
16
20
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
7.5
80
413
ZXY03
NOMESCO Finland
Occupational therapist
11.9
7.5
13
11
R4110
NOMESCO Finland
Physiotherapy
1.9
7.5
115
676
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.6
7.5
18
40
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.0
7.5
21
53
N06AX11
ATC
mirtazapine; oral
1.9
7.4
104
594
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
79.8
7.4
8
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.1
7.3
31
103
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.7
7.3
16
21
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.4
7.3
18
41
ZYB06
NOMESCO Finland
Outreach service in patient's nursery
+∞
7.3
7
*
S29
ICPC
Skin symptom/complaint other
2.0
7.2
85
456
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
7.2
52
229
RT490, ,
NOMESCO Finland
15.7
7.2
11
7
N05AF03
ATC
chlorprothixene; systemic
5.8
7.2
19
33
N03AX14
ATC
levetiracetam; systemic
3.9
7.1
21
55
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
7.1
78
408
T90
ICPC
Diabetes non-insulin dependent
2.9
7.1
34
122
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.7
7.0
38
145
L60.0
ICD-10 Finland
Ingrowing nail
3.2
7.0
27
85
A29
ICPC
General symptom/complaint other
2.3
6.9
58
272
N05BA04
ATC
oxazepam; oral
2.0
6.9
79
419
DFF00
NOMESCO Finland
Pure tone audiometry
3.0
6.9
31
107
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.4
6.9
17
27
E66.9
ICD-10 Finland
Obesity, unspecified
3.7
6.8
21
57
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.7
6.8
21
57
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
39.9
6.7
8
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
39.9
6.7
8
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.5
6.7
41
167
D11
ICPC
Diarrhoea
2.0
6.7
82
446
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.1
6.6
28
93
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
22.4
6.6
9
*
N17
ICPC
Vertigo/dizziness
2.5
6.6
42
174
RS222, ,
NOMESCO Finland
6.5
6.6
16
25
RT160, ,
NOMESCO Finland
7.8
6.6
14
18
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
5.9
6.6
17
29
Z61.8
ICD-10 Finland
Other negative life events in childhood
12.2
6.5
11
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.5
133
849
E66.01
ICD-10 Finland
Obesity due to excess calories
2.4
6.5
46
201
C03DA01
ATC
spironolactone; oral
3.4
6.4
23
69
R1250
NOMESCO Finland
Evaluation of functional capability
6.2
6.4
16
26
R32
ICD-10 Finland
Unspecified urinary incontinence
6.2
6.4
16
26
N05AD01
ATC
haloperidol; systemic
6.2
6.4
16
26
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
69.4
6.4
7
*
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
7.4
6.4
14
19
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
14.3
6.3
10
7
RT130, ,
NOMESCO Finland
14.3
6.3
10
7
Z29.8
ICD-10 Finland
Other specified prophylactic measures
2.8
6.3
32
118
H81
ICPC
Excessive ear wax
2.4
6.3
42
178
P72
ICPC
Schizophrenia
5.2
6.3
18
35
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.9
6.2
29
102
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
5.5
6.2
17
31
Z31.5
ICD-10 Finland
Genetic counselling
2.4
6.2
42
179
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
9.3
6.2
12
13
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
9.3
6.2
12
13
F80.0
ICD-10 Finland
Specific speech articulation disorder
9.3
6.2
12
13
C02AC02
ATC
guanfacine; oral
18.0
6.2
9
5
L20
ICPC
Joint symptom/complaint NOS
4.1
6.2
17
42
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
6.2
6
*
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
6.2
6
*
A06AD11
ATC
lactulose; oral
2.7
6.2
33
125
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
26.5
6.2
8
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
3.9
6.1
18
47
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.7
6.0
33
127

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
231
1424
2.20
15.10
3.2
2.2
—
—
—
0
0
188
1119
2.11
12.91
8.2
9.1
—
—
—
0
0
328
2426
2.18
12.26
4.5
3.4
14.38
14.50
pmol/l
0.43
313
2252
388
3094
2.60
11.88
13.2
10.8
139.45
139.38
mmol/l
0.22
382
2993
388
3097
2.59
11.80
12.9
10.7
3.92
3.94
mmol/l
0.52
382
2977
20
37
5.50
10.20
28.6
27.5
1431.75
1281.73
nmol/l
0.44
20
37
217
1445
1.91
10.16
7.2
10.1
1.22
1.22
mmol/l
0.05
202
1329
356
2814
2.12
9.82
5.3
3.8
1.93
1.86
mu/l
0.74
344
2647
304
2285
1.92
9.54
4.1
2.4
5.84
5.52
mmol/l
2.34
291
2091
266
1939
1.83
8.93
5.9
5.8
107.31
105.48
u/l
0.15
255
1830
183
1191
1.85
8.89
3.2
3.3
66.15
70.24
nmol/l
1.26
175
1129
288
2180
1.81
8.23
12.6
10.8
3.71
3.64
e9/l
0.22
243
1820
77
379
2.19
8.22
1.5
1.3
19.36
19.10
nmol/l
0.06
71
340
236
1703
1.75
7.78
5.0
6.4
6.18
6.26
mmol/l
0.18
226
1551
119
704
1.89
7.62
2.4
2.9
50.54
58.26
u/l
1.52
114
663
49
208
2.47
7.33
3.6
3.6
—
—
—
0
0
122
745
1.83
7.00
2.1
3.0
2.39
2.38
mmol/l
0.35
116
684
150
975
1.76
6.97
4.7
7.7
37.17
37.86
g/l
0.75
143
937
104
611
1.87
6.72
3.4
4.2
7.39
7.40
ph
0.21
17
104
126
786
1.79
6.70
4.0
4.8
7.96
8.44
mmol/l
0.43
120
741
259
1981
1.66
6.38
8.1
9.0
0.04
0.04
e9/l
0.28
215
1658
265
2039
1.66
6.37
8.7
9.8
0.19
0.22
e9/l
1.54
225
1744
47
209
2.34
6.36
2.2
1.6
484.76
301.41
mu/l
1.65
42
190
391
3364
2.02
6.25
9.9
8.3
31.76
28.49
u/l
1.03
382
3261
46
205
2.33
6.19
1.5
1.5
883.47
1100.48
nmol/l
0.84
38
162
258
1985
1.64
6.09
8.0
9.0
0.57
0.56
e9/l
0.28
216
1666
246
1872
1.63
6.06
7.5
9.2
—
—
—
0
0
57
283
2.11
5.92
1.3
1.8
—
—
—
0
0
266
2077
1.62
5.79
4.9
3.4
37.43
37.05
mmol/mol
0.21
257
1976
11
12
9.17
5.74
1.6
2.4
22.61
16.49
umol/l
0.50
11
12
244
1874
1.60
5.63
8.4
9.1
0.67
0.64
%
0.31
227
1801
168
1182
1.62
5.57
5.0
7.1
16.32
17.47
umol/l
0.17
159
1105
106
671
1.72
5.23
2.0
1.6
98.44
95.14
pmol/l
0.32
61
374
241
1873
1.56
5.08
10.1
10.2
0.00
0.00
e9/l
1.07
189
1422
59
314
1.97
5.08
4.5
3.8
—
—
—
0
0
117
770
1.66
4.97
7.3
5.4
1.10
1.10
inr
0.01
33
226
245
1924
1.54
4.84
8.4
8.9
2.77
3.29
%
2.76
229
1847
246
1939
1.53
4.74
8.4
9.0
8.21
8.27
%
0.18
232
1865
260
2075
1.54
4.72
8.2
8.8
2.36
2.28
e9/l
0.59
222
1798
162
1169
1.56
4.66
4.6
4.8
13.59
34.75
e6/l
1.83
110
793
115
765
1.63
4.65
2.6
3.1
3.20
2.65
mg/l
0.80
106
680
19
63
3.04
4.56
6.9
8.2
—
—
—
0
0
53
283
1.95
4.52
3.4
12.4
1.39
1.43
mmol/l
0.12
53
275
110
734
1.62
4.37
2.8
3.1
—
—
—
0
0
71
422
1.77
4.33
1.9
1.7
—
—
—
0
0
8
263
0.29
4.28
1.4
1.3
—
—
—
0
0
20
458
0.40
4.10
1.2
1.3
—
—
—
0
0
164
1214
1.51
4.09
2.8
3.0
6.46
6.04
ph
0.84
13
147
99
655
1.62
4.05
3.3
2.9
1.02
1.02
kg/l
0.06
14
116
29
128
2.30
4.03
6.9
14.9
128.00
126.64
g/l
0.12
29
123
100
666
1.61
3.98
3.5
3.1
600.12
589.65
mosm/kgh2o
0.13
85
581
138
991
1.52
3.95
4.0
4.1
12.75
103.75
e6/l
0.79
107
765
88
569
1.64
3.94
3.6
4.2
—
—
—
0
0
247
2000
1.46
3.85
8.1
8.6
50.77
50.69
%
0.03
233
1931
17
59
2.90
3.80
2.8
2.2
—
—
—
0
0
67
407
1.72
3.79
3.4
2.5
—
—
—
0
0
49
274
1.84
3.66
5.1
11.0
104.49
104.99
mmol/l
0.40
49
274
128
921
1.50
3.58
3.8
3.9
0.17
0.22
e6/l
0.29
96
703
88
587
1.58
3.46
5.0
9.8
—
—
—
0
0
128
931
1.48
3.38
3.7
3.8
—
—
—
0
0
248
2041
1.42
3.36
8.5
8.7
34.06
34.38
%
0.17
235
1968
51
796
0.58
3.35
1.7
1.8
—
—
—
0
0
277
2327
1.43
3.33
3.8
2.7
1.31
1.18
mmol/l
1.46
270
2199
60
367
1.69
3.32
3.5
3.8
112.85
114.77
mg/l
0.01
43
276
291
2473
1.43
3.24
4.2
2.9
4.31
4.54
mmol/l
4.52
284
2353
18
72
2.51
3.12
4.2
10.6
—
—
—
0
0
34
178
1.94
3.11
5.1
13.4
12.62
15.37
kpa
1.92
34
170
34
178
1.94
3.11
5.2
13.4
5.41
5.25
kpa
0.38
34
170
34
178
1.94
3.11
6.3
13.4
1.43
0.33
mmol/l
0.96
29
146
31
157
2.00
3.11
6.5
14.9
93.98
95.36
%
0.22
31
152
289
2463
1.41
3.10
4.3
2.9
2.68
2.80
mmol/l
1.52
280
2319
287
2449
1.41
3.01
4.0
2.8
1.30
1.39
mmol/l
3.65
280
2320
59
369
1.65
3.01
3.3
2.7
—
—
—
0
0
82
556
1.54
2.99
3.3
3.5
1.24
1.71
e6/l
0.42
49
320
59
371
1.64
2.95
4.2
4.3
6.86
15.63
mg/mmol
0.97
41
270
92
642
1.51
2.94
3.9
9.1
1.09
1.13
mmol/l
0.06
70
501
86
592
1.52
2.93
1.7
1.8
1.50
1.36
mmol/l
0.55
77
544
30
154
1.97
2.91
1.4
1.3
—
—
—
0
0
8
18
4.41
2.75
1.1
1.1
—
—
—
0
0
87
610
1.49
2.71
7.5
7.3
7.40
7.40
ph
—
5
20
15
59
2.54
2.70
1.5
10.3
—
—
—
0
0
83
577
1.50
2.70
4.1
8.9
23.36
23.54
mmol/l
0.32
83
577
8
19
4.18
2.64
2.5
2.9
227.00
149.53
ug/g
—
8
19
115
856
1.42
2.63
4.8
7.2
87.14
88.68
%
0.29
115
844
96
691
1.46
2.63
4.1
3.4
0.00
0.00
estimate
0.50
26
262
390
3558
1.53
2.56
11.3
7.6
—
—
—
0
0
18
81
2.23
2.46
2.3
2.0
—
—
—
0
0
13
50
2.59
2.45
2.6
3.8
18.24
17.36
%
—
7
29
15
63
2.38
2.38
1.7
1.4
—
—
—
0
0
64
434
1.52
2.34
3.2
2.5
—
—
—
0
0
14
58
2.41
2.29
3.3
8.7
1.58
2.82
mmol/l
—
9
26
385
3525
1.47
2.25
12.1
9.9
21.83
22.38
mg/l
0.12
285
2454
91
670
1.41
2.20
3.4
3.3
10.04
5.29
e6/l
1.45
81
598
257
2215
1.32
2.19
4.1
4.0
7.65
7.31
mm/h
0.19
241
2082
67
468
1.47
2.14
3.1
2.5
—
—
—
0
0
67
468
1.47
2.14
3.0
2.4
—
—
—
0
0
172
1407
1.32
2.12
3.6
3.2
0.00
0.00
estimate
-0.00
30
268
67
470
1.47
2.09
3.2
2.4
—
—
—
0
0
101
1249
0.73
2.02
2.3
2.2
—
—
—
0
0
433
4089
1.86
2.01
21.1
14.7
267.42
263.41
e9/l
0.62
414
3932
23
124
1.86
1.99
7.0
14.2
1.77
1.27
%
0.72
23
124
19
97
1.96
1.93
3.3
12.9
23.53
23.28
mmol/l
0.12
19
92
433
4095
1.82
1.90
21.0
14.6
86.50
86.89
fl
0.83
428
4047
433
4095
1.82
1.90
21.1
14.6
4.75
4.68
e12/l
2.39
414
3930
433
4095
1.82
1.90
21.0
14.6
29.03
29.30
pg
2.09
428
4046
65
463
1.44
1.88
3.1
2.2
—
—
—
0
0
14
64
2.18
1.87
2.1
6.6
—
—
—
0
0
433
4098
1.81
1.85
21.2
14.9
137.43
136.57
g/l
0.57
428
4048
8
28
2.83
1.82
1.0
3.1
—
—
—
0
0
76
967
0.72
1.80
2.0
1.7
—
—
—
0
0
432
4090
1.76
1.78
21.1
15.2
40.80
40.38
%
0.96
415
3939
12
53
2.25
1.74
1.7
1.8
—
—
—
0
0
22
123
1.79
1.73
7.2
14.3
0.64
0.73
%
0.51
22
123
41
272
1.52
1.69
2.2
2.1
2.40
2.41
mmol/l
0.22
34
235
236
2055
1.26
1.68
3.9
3.6
43.63
31.76
u/l
2.64
227
1984
168
1409
1.27
1.63
4.8
4.6
0.00
0.00
estimate
-0.00
29
275
6
19
3.12
1.63
2.7
1.5
—
—
—
0
0
432
4099
1.71
1.63
21.3
14.7
6.92
6.92
e9/l
0.02
413
3935
169
1422
1.26
1.59
3.7
3.2
0.00
0.00
estimate
-0.00
30
260
22
129
1.71
1.50
2.8
3.2
—
—
—
0
0
88
1067
0.76
1.49
2.0
1.8
—
—
—
0
0
7
27
2.56
1.48
1.1
1.1
—
—
—
0
0
9
37
2.41
1.47
2.4
3.6
—
85.80
—
0
10
56
408
1.39
1.46
3.4
3.2
188.53
1636.89
ng/l
3.09
34
217
9
174
0.50
1.43
1.2
1.4
—
—
—
0
0
73
558
1.34
1.42
3.2
2.2
13.92
72.84
ng/l
0.79
42
207
74
912
0.76
1.41
2.5
1.9
—
—
—
0
0
17
94
1.80
1.41
7.5
19.3
—
—
—
0
0
6
22
2.69
1.40
1.8
2.0
4.32
6.06
ug/l
—
6
22
9
40
2.23
1.38
4.6
15.1
1.07
0.91
%
—
9
35
78
605
1.32
1.37
4.0
2.3
—
—
—
0
0
17
95
1.78
1.36
1.5
1.5
—
—
—
0
0
0
37
0.00
1.35
0.0
1.4
—
222.20
—
0
37
235
2079
1.22
1.34
4.4
3.9
—
—
—
0
0
5
17
2.90
1.33
1.0
1.0
—
—
—
0
0
6
24
2.47
1.27
1.2
1.1
—
—
—
0
0
6
24
2.47
1.27
1.0
1.1
—
—
nmol/l
—
0
0
6
25
2.37
1.21
1.2
1.1
—
—
—
0
0
42
302
1.40
1.20
3.9
2.7
16986.89
3834.49
u/l
—
9
130
8
37
2.14
1.19
1.0
1.1
127.25
244.66
mg/l
—
8
32
12
64
1.86
1.12
11.2
14.6
25.07
23.82
mmol/l
0.59
12
59
5
20
2.47
1.12
1.2
1.1
—
—
—
0
0
8
40
1.98
1.10
1.9
15.1
1.71
1.37
%
—
8
34
6
119
0.49
1.07
1.0
1.1
—
—
—
0
0
5
21
2.35
1.06
6.6
26.1
11.00
11.50
mmol/l
—
5
16
5
21
2.35
1.06
6.6
26.1
106.60
105.25
mmol/l
—
5
16
7
33
2.10
1.04
3.6
1.8
—
—
—
0
0
9
154
0.56
1.00
4.3
4.1
8.43
10.15
umol/l
—
9
124
7
35
1.98
0.98
7.6
2.9
9.03
5.37
mmol/l
—
7
30
36
263
1.37
0.97
4.6
7.3
54.92
51.85
ng/l
0.24
36
257
29
204
1.42
0.96
6.3
5.0
0.00
0.07
%
—
9
71
0
31
0.00
0.96
0.0
7.1
—
—
—
0
0
51
395
1.30
0.94
1.3
1.3
—
247.56
—
0
16
6
27
2.19
0.92
3.7
2.6
35366.67
41766.67
ug/l
—
6
27
10
54
1.83
0.92
2.1
5.3
24.40
25.24
umol/l
—
10
54
28
198
1.41
0.91
6.4
5.1
0.00
0.08
%
—
8
64
10
166
0.58
0.90
1.4
1.5
—
—
—
0
0
6
29
2.04
0.88
1.0
1.7
8.33
8.32
umol/l
—
6
29
10
55
1.80
0.87
1.1
1.1
—
—
—
0
0
10
164
0.59
0.87
1.4
1.4
—
—
—
0
0
10
163
0.59
0.85
1.4
1.4
—
—
—
0
0
16
102
1.56
0.85
4.4
3.7
—
—
—
0
0
6
31
1.91
0.83
6.8
5.3
20.96
22.75
ug/l
—
6
31
6
31
1.91
0.83
1.0
1.0
168.50
162.81
g/l
—
6
31
6
32
1.85
0.80
7.7
5.8
4.02
3.81
mmol/l
—
6
32
30
221
1.35
0.79
1.5
2.3
0.84
0.99
ug/l
0.54
25
202
16
104
1.53
0.79
1.1
1.1
—
—
—
0
0
29
213
1.36
0.78
6.3
4.9
0.28
0.79
%
—
9
80
6
33
1.79
0.77
2.5
1.3
—
—
—
0
0
8
129
0.60
0.74
1.3
1.6
—
9.04
—
0
7
5
24
2.05
0.74
1.6
3.3
1.14
1.00
umol/l
—
5
24
12
74
1.61
0.73
1.2
1.1
—
—
—
0
0
12
74
1.61
0.73
1.2
18.7
—
—
—
0
0
13
82
1.57
0.73
1.4
1.1
—
—
—
0
0
71
592
1.21
0.72
2.5
4.0
2.07
1.49
mg/l
0.35
45
411
24
174
1.37
0.71
1.2
1.1
—
—
—
0
0
33
252
1.31
0.70
1.9
2.0
10.55
11.48
iu/l
0.11
20
168
7
40
1.73
0.70
5.9
15.7
0.83
1.19
mmol/l
—
7
31
18
124
1.44
0.70
1.6
12.8
0.83
0.66
%
0.67
18
124
14
92
1.51
0.67
2.7
2.3
—
—
—
0
0
13
84
1.53
0.67
1.0
1.4
435.80
382.93
ug/g
—
5
45
71
597
1.20
0.67
1.2
1.2
—
—
—
0
0
24
176
1.36
0.67
4.8
9.2
0.15
0.29
g/l
2.01
14
147
7
43
1.60
0.65
1.1
1.1
—
—
—
0
0
12
174
0.67
0.65
2.0
2.0
—
—
—
0
0
18
126
1.42
0.65
2.4
1.9
—
—
—
0
0
5
28
1.76
0.65
1.0
1.2
—
—
—
0
0
5
28
1.76
0.65
7.6
2.1
—
—
—
0
0
11
69
1.58
0.64
4.0
7.3
—
—
—
0
0
145
1297
1.14
0.63
1.7
1.6
1.71
1.72
g/l
0.03
74
691
49
400
1.23
0.63
2.5
2.5
324.31
347.33
nmol/l
0.33
49
382
33
257
1.28
0.62
2.4
5.2
69.07
64.82
e9/l
0.18
19
155
0
19
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
71.86
—
0
21
0
21
0.00
0.60
0.0
4.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
8
51
1.55
0.59
7.0
2.9
0.50
1.60
%
—
8
45
32
389
0.79
0.59
1.3
1.7
—
—
—
0
0
10
147
0.66
0.59
1.5
1.1
—
—
—
0
0
8
53
1.49
0.57
1.5
1.8
139.75
136.40
ng/l
—
8
53
10
146
0.66
0.57
1.5
1.1
—
—
—
0
0
5
88
0.55
0.56
1.4
1.4
—
—
—
0
0
6
36
1.64
0.56
1.8
1.8
—
—
—
0
0
11
156
0.68
0.55
1.0
1.1
—
—
—
0
0
152
1377
1.12
0.54
1.8
1.7
1.67
3.03
u/ml
0.54
24
247
17
123
1.37
0.53
1.2
1.3
—
—
—
0
0
37
300
1.23
0.52
1.6
1.9
1.09
0.95
g/l
0.56
37
287
33
265
1.24
0.51
1.8
2.0
4.45
6.02
u/l
0.75
18
173
6
40
1.48
0.50
1.5
3.1
12.33
13.08
umol/l
—
6
40
30
239
1.25
0.49
1.9
2.2
—
16.91
—
0
18
64
550
1.16
0.49
8.7
6.8
—
—
—
0
0
7
44
1.57
0.49
1.0
2.7
—
—
—
0
0
18
134
1.33
0.48
2.1
1.6
—
—
—
0
0
48
404
1.18
0.47
3.7
6.2
6.94
7.31
umol/l
0.08
42
333
13
173
0.73
0.47
1.1
1.1
—
4.21
—
0
8
79
859
0.88
0.45
1.7
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
3.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
10
69
1.43
0.41
2.7
4.9
—
—
—
0
0
12
86
1.38
0.41
1.4
1.3
1.56
12.89
u/ml
—
6
73
5
33
1.49
0.41
1.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
52
449
1.15
0.39
1.4
1.5
268.57
473.24
titre
—
7
71
25
295
0.82
0.39
2.0
2.0
—
—
—
0
0
6
42
1.41
0.35
3.8
5.3
—
—
—
0
0
22
178
1.22
0.34
1.7
1.6
—
—
—
0
0
6
46
1.28
0.32
1.7
9.2
—
—
—
0
0
14
109
1.27
0.30
2.4
5.5
—
—
—
0
0
16
127
1.24
0.29
1.3
1.4
0.62
2.65
u/ml
1.63
11
85
10
74
1.33
0.29
1.1
1.2
—
—
—
0
0
20
232
0.84
0.28
1.5
1.5
—
—
—
0
0
9
115
0.76
0.27
1.9
1.8
—
—
—
0
0
8
63
1.25
0.27
5.0
4.1
3.61
3.20
e9/l
—
8
63
70
741
0.91
0.27
2.7
3.1
60.48
113.41
ug/g
1.99
61
602
8
65
1.21
0.26
5.0
4.1
51.63
50.97
%
—
8
65
37
323
1.13
0.26
1.9
1.4
—
—
—
0
0
9
71
1.25
0.25
4.9
6.2
4.65
1.74
ug/l
—
9
71
18
148
1.20
0.25
2.2
4.7
—
—
—
0
0
11
134
0.80
0.24
2.3
1.6
30.82
36.15
nmol/l
0.29
11
129
14
165
0.83
0.23
1.3
1.6
—
—
—
0
0
13
104
1.23
0.23
1.7
6.6
24.76
24.29
mmol/l
0.29
13
99
47
421
1.11
0.23
1.3
1.2
9.69
18.91
iu/ml
—
10
104
42
375
1.11
0.22
2.4
2.0
—
—
—
0
0
168
1588
1.06
0.21
3.1
3.2
378.72
67.95
ug/l
0.49
155
1508
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
19
215
0.86
0.21
1.4
1.9
170.50
166.23
u/ml
0.04
14
105
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
0
13
0.00
0.20
0.0
1.5
—
—
—
0
0
23
198
1.15
0.20
1.2
1.2
—
—
—
0
0
6
48
1.23
0.20
3.8
4.8
—
—
—
0
0
18
203
0.86
0.19
1.3
1.4
288.31
261.99
miu/ml
—
7
101
6
50
1.18
0.19
1.2
1.0
—
—
—
0
0
11
130
0.83
0.19
1.4
1.1
—
—
—
0
0
134
1265
1.05
0.18
2.7
3.0
—
—
—
0
0
32
285
1.11
0.18
1.5
1.4
—
—
—
0
0
7
60
1.15
0.17
2.4
3.3
549.29
721.42
e6/l
—
7
60
7
61
1.13
0.17
1.1
1.7
—
—
—
0
0
5
67
0.73
0.17
1.2
1.1
—
—
—
0
0
44
400
1.09
0.17
1.3
1.2
19.13
8.23
u/ml
0.27
15
140
16
137
1.15
0.15
1.3
1.5
1.22
1.16
g/l
0.45
16
131
7
85
0.80
0.14
3.3
4.1
17.43
13.04
%
—
7
85
113
1147
0.95
0.14
1.4
1.6
—
—
—
0
0
29
262
1.09
0.13
1.2
1.2
—
—
—
0
0
74
755
0.95
0.11
4.0
2.8
—
—
—
0
0
27
245
1.09
0.11
4.2
3.5
—
—
—
0
0
33
304
1.07
0.10
1.3
1.3
50.18
142.47
iu/ml
—
8
113
48
493
0.95
0.10
3.4
6.2
31.00
30.58
s
0.18
48
488
94
896
1.04
0.09
2.6
2.9
—
—
—
0
0
29
302
0.94
0.09
1.2
1.2
1.38
3.25
u/ml
1.08
21
231
7
62
1.11
0.08
1.1
1.4
—
—
—
0
0
8
72
1.09
0.07
6.8
4.6
—
—
—
0
0
7
82
0.83
0.07
3.3
3.8
9.00
10.56
%
—
7
82
7
82
0.83
0.07
3.3
3.7
70.57
70.26
%
—
7
82
9
85
1.04
0.07
3.0
6.8
—
—
—
0
0
20
184
1.07
0.06
1.2
1.2
—
—
—
0
0
16
168
0.93
0.05
1.3
1.1
0.11
0.33
u/ml
—
7
85
11
98
1.10
0.05
1.1
1.1
—
—
—
0
0
21
216
0.95
0.04
1.1
1.1
—
—
—
0
0
30
305
0.96
0.04
1.2
1.2
0.51
0.79
u/ml
0.42
22
223
12
109
1.08
0.03
1.1
1.2
—
—
—
0
0
12
125
0.94
0.02
1.7
1.7
—
—
—
0
0
40
398
0.98
0.00
10.0
13.4
5.16
5.62
mmol/l
0.49
40
392
10
93
1.06
0.00
1.2
1.3
—
—
—
0
0
18
174
1.01
0.00
1.2
1.1
5.59
10.40
u/ml
0.69
11
104
19
189
0.98
0.00
1.2
1.1
3.98
7.09
u/ml
0.39
14
126
40
395
0.99
0.00
1.8
1.5
—
—
—
0
0
66
651
0.99
0.00
2.1
1.6
—
—
—
0
0
31
309
0.98
0.00
1.2
1.2
2.80
6.65
u/ml
1.84
24
241
47
456
1.01
0.00
1.9
4.2
330.19
1914.94
umol/l
0.79
42
427
38
375
0.99
0.00
1.7
1.4
290.16
304.35
u/ml
0.04
38
352
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
73
0.94
0.00
1.6
19.9
76.57
72.97
%
—
7
73
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
15.65
—
0
6
0
6
0.00
0.00
0.0
21.8
—
14.48
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
190.40
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
0.39
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.6
—
14.06
—
0
9
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.93
-0.00
1.0
1.0
19.78
19.50
mmol/l
—
9
95
0
8
0.00
-0.00
0.0
1.1
—
1786.88
—
0
8
7
74
0.93
-0.00
3.3
3.8
25.86
26.39
%
—
7
74
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
64.99
—
0
7
0
7
0.00
-0.00
0.0
4.4
—
0.44
—
0
7
9
95
0.93
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.0
—
139.14
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
84
0.93
-0.00
7.9
4.8
2.57
5.55
u/ml
—
8
84
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
9.2
—
24.67
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.6
—
5.88
—
0
8
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_PSYCHDEVOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_PSYCHDEVOTH.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: F5_PSYCHDEVOTH – Other and unspecified disorders of psychological development

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data